Cota Chief Scientific Officer to Present at the ACCC Annual Meeting & Cancer Center Business Summit

NEW YORK, March 15, 2018 /PRNewswire/ -- Cota Inc., a real-world data and analytics company bridging precision medicine to population health, today announced its chief scientific officer, Stuart Goldberg, M.D., will speak today, Thursday, March 15 at the Association of Community Cancer Centers (ACCC) 44^th Annual Meeting and Cancer Center Business Summit in Washington D.C. The event, taking place at the Renaissance Washington, D.C. Downtown Hotel, brings together leading experts to explore innovation in oncology and discuss approaches for navigating business and policy changes in cancer care.

Dr. Goldberg will be speaking during a panel titled "Preparing for Commercial Bundles in Oncology," under the policy track. He will provide an overview of how Cota assists practices in preparing for bundle programs and why practices need a complete understanding of the types of patients they see and the associated costs. Cota's precise disease classification system, the Cota Nodal Addresstm (CNA), is the market leader in facilitating commercial bundle design. It considers differences in patients with cancer and breaks them into smaller cohorts of similar patients, thus facilitating bundle design. Representatives from Horizon Blue Cross Blue Shield of New Jersey and Archway Health will also be speaking on the panel.

Cota's CNA is a breakthrough method of precisely classifying patients and their diseases using a concise digital code to enable innovation in precision medicine. The patented system organizes the complexities of patients and their diseases in a form that permits detailed analysis of outcomes, toxicities, practice patterns, care variances and cost. It then assesses these factors to build a bundled program where the provider understands the average costs and where savings can be made.

For those interested in attending Dr. Goldberg's presentation, please refer to the following information:

• What: "Preparing for Commercial Bundles in Oncology" session
• Who: Dr. Stuart Goldberg, chief scientific officer of Cota
• When: Thursday, March 15 at 3:20 p.m. ET
• Where: Renaissance Washington, D.C. Downtown Hotel, Washington D.C.

For more information or to schedule a meeting with Cota representatives at the event, please reach out to Cota via [email protected].

About Cota 
Cota is a real-world data and analytics company that enables providers, payers and life science companies involved in diagnosing and treating complex diseases to optimize the outcomes of individual patients and lower the overall cost of the patient population served. It is powered by the patented Cota Nodal Addresstm (CNA) system, a unique digital classification methodology built by leading physicians and data scientists. The CNA is the first and only system that precisely categorizes patient factors, their diseases and intended therapies, enabling precision medicine at scale.

Cota's technology enriches medical records to create research-grade data and joins it with a suite of analysis, visualization and management tools. This enables providers, payers and life science companies to analyze, report on and research outcomes, costs, treatments and quality at any granularity and stage of the patient journey. The result is a constantly improving system that merges technology and medicine to improve the lives of patients everywhere. For more information, go to www.cotahealthcare.com. 

Alessandra Nix
SHIFT Communications
[email protected]   
617.779.1860

SOURCE Cota